A retrospective study of incidence of severe COVID-19 illness in patients who received vaccine and a booster vaccine dose
Latest Information Update: 29 Sep 2022
At a glance
- Drugs Ad26.COV2 S (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
Most Recent Events
- 29 Sep 2022 New trial record
- 26 Sep 2022 Results published in the JAMA: the Journal of the American Medical Association